Martin Hirtl

6PUBLICATIONS
25CO-AUTHORS
PsychopharmacologyCancer therapy (excl. chemotherapy and radiation therapy)Quality assurance, chemometrics, traceability and metrological chemistryElectrical energy generation (incl. renewables, excl. photovoltaics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2026
Presenilin-1 controls glycolysis and identity of pancreatic beta cells.

|Sep 26, 2025
Enhancing Late-Life Survival and Mobility via Mitohormesis by Reducing Mitochondrial Calcium Levels.

Doruntina Bresilla, Ines Tawfik, Martin Hirtl

|May 09, 2025
Annexin A5 controls VDAC1-dependent mitochondrial Ca2+ homeostasis and determines cellular susceptibility to apoptosis.

Furkan E Oflaz, Alexander I Bondarenko, Michael Trenker

|Jul 01, 2022
MICU1 controls spatial membrane potential gradients and guides Ca2+ fluxes within mitochondrial substructures.

Benjamin Gottschalk, Zhanat Koshenov, Markus Waldeck-Weiermair

|Jun 24, 2022
Sigma-1 Receptor Modulation by Ligands Coordinates Cancer Cell Energy Metabolism.

Furkan E Oflaz, Zhanat Koshenov, Martin Hirtl

|Jul 02, 2021
Sigma-1 Receptor Promotes Mitochondrial Bioenergetics by Orchestrating ER Ca2+ Leak during Early ER Stress.

Zhanat Koshenov, Furkan E Oflaz, Martin Hirtl

Pageof 1

Frequent Collaborators

5 joint publications

Roland Malli

5 joint publications

Wolfgang F Graier

4 joint publications

Furkan E Oflaz

3 joint publications

Zhanat Koshenov